# NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE
> **ANDA209726** · Abbreviated New Drug Application (Generic) · Sponsor: AMNEAL PHARMS CO · Approved 2018-10-23
## Drug
- **FDA Application Number:** ANDA209726
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE
- **Generic name:** NAPROXEN SODIUM
- **Active ingredients:** DIPHENHYDRAMINE HYDROCHLORIDE; NAPROXEN SODIUM
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** AMNEAL PHARMS CO
- **Manufacturer:** Strategic Sourcing Services LLC
- **First approval:** 2018-10-23
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209726)
---
*AI Analytics · CC0 1.0*